Related Experiment Video
Updated: May 2, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
[Chemotherapy induced peripheral neuropathy]
Agnieszka Kolak1, Elzbieta Starosławska1, Tomasz Kubiatowski1
1Centrum Onkologii Ziemi Lubelskiej im. sw. Jana z Dukli w Lublinie.
Cancer treatments can cause chemotherapy-induced peripheral neuropathy (CIPN), leading to sensory, motor, and autonomic issues. Standardized diagnostic and treatment methods are still needed for this common complication.
Area of Science:
- Oncology
- Neurology
- Pharmacology
Context:
- Cancer therapies improve survival but often cause treatment-related complications.
- Neurotoxicity, specifically chemotherapy-induced peripheral neuropathy (CIPN), is a significant adverse effect.
- CIPN presents with diverse sensory, motor, and autonomic symptoms, impacting patient quality of life.
Purpose:
- To highlight the challenges in diagnosing and managing CIPN.
- To discuss current symptomatic treatment approaches for CIPN.
- To emphasize the importance of patient education regarding CIPN.
Summary:
- CIPN is a common complication of cancer therapy, characterized by sensory, motor, and autonomic dysfunction.
- Despite extensive research, standardized diagnostic criteria and effective prevention/treatment strategies for CIPN remain elusive.
- Current management primarily involves symptomatic treatments like anticonvulsants and antidepressants, alongside patient education.
Impact:
- Addresses a critical unmet need in supportive cancer care.
- Informs clinicians and researchers about the current state of CIPN management.
- Underscores the importance of a multidisciplinary approach to mitigate treatment-related toxicities in cancer patients.
More Related Videos
04:48Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Diabetic Neuropathy
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Local Anesthetics: Differential Sensitivity of Nerve Fibers